CAC2 Childhood Cancer Community News Digest (October 23-29)
Assorted News from the Last Week:
The frequency of cellular therapy trial activations enrolling child/AYA patients with cancer in the U.S. has increased over time. Most studies were phase 1 or 2, single institution-only, and not industry-supported. Future opportunities for cell therapy for pediatric cancer should include multi-institutional approaches.
ChatGPT shows promise in predicting cancer predisposition genes from clinical notes and could be a promising tool for pediatric oncologists.
The miraculous life-saving power of a bed: Pediatric cancer in Uganda.
NPR feature story: The hospital ran out of her child’s cancer drug. Now she’s fighting to end shortages.
Upcoming Webinars, Online Opportunities, and Meetings:
Join the Ross K. MacNeill Foundation at their 2023 Orange Tie Gala for pediatric brain cancer research, November 4, 6:30-11:00pm CT. Learn more and register.
Triage Cancer will offer a webinar on Cancer Caregivers on November 15 at 11:30 ET about the rights of caregivers at work, how to replace lost wages while acting as a caregiver, and practical tips to support caregivers. Learn more and register.
Take Action:
A Draft Scientific Integrity Policy of the National Institutes of Health was released for public comment. The draft policy articulates the procedures and processes in place at NIH that help maintain rigorous scientific integrity practices. Additionally, the draft policy proposes several new functions to further enhance scientific integrity at NIH and throughout the biomedical research enterprise. Comments will be accepted until November 9, 2023.
Phase 1/2 trial which aims to determine the safety and feasibility of anti-CD33 chimeric antigen receptor (CAR) expressing T cells (CD33CART) in children and adolescents/young adults (AYAs) with relapsed/refractory acute myeloid leukemia (AML). The trial will be done in two phases: Phase 1 will determine the maximum tolerated dose of CD33CART cells using a 3+3 trial design. Phase 2 is an expansion phase designed to evaluate the rate of response to CD33CART.
To help spread the word about the Childhood Cancer Data Initiative (CCDI), the National Cancer Institute has created a communications toolkit with a CCDI overview flyer, a one-pager with frequently asked questions about the CCDI Data Ecosystem, and sample social media posts and graphics. Access the toolkit, and feel free to reference, copy, and use its content for inspiration.
SUBSCRIBE
Sign up to receive a copy of CAC2's free childhood cancer news digest in your inbox each week.
Categories
- Blog Posts (92)
- Explainer Post (11)
- Guest Blogs (15)
- Member Blogs (38)
- Survivorship Matters Blog (9)
- CAC2 News (25)
- Collaborative Achievements (14)
- Community News (244)
- In Memoriam (2)
- News Digest (197)
- Webinars (64)
Tags
Recent Posts
- CAC2 Childhood Cancer Community News Digest (September 30-October 6)
- CAC2 Childhood Cancer Community News Digest (September 23-29)
- CAC2 Childhood Cancer Community News Digest (September 16-22)
- CAC2 Childhood Cancer Community News Digest (September 9-15)
- CAC2 Childhood Cancer Community News Digest (September 2-8)